Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 4
1946 5
1947 5
1948 4
1949 1
1950 2
1951 3
1952 2
1953 3
1954 4
1958 2
1960 1
1961 1
1962 3
1963 2
1964 2
1965 2
1968 1
1969 5
1970 13
1971 58
1972 146
1973 234
1974 217
1975 171
1976 219
1977 214
1978 217
1979 166
1980 187
1981 185
1982 137
1983 145
1984 146
1985 132
1986 126
1987 147
1988 119
1989 115
1990 146
1991 177
1992 123
1993 146
1994 137
1995 215
1996 198
1997 244
1998 341
1999 335
2000 379
2001 442
2002 518
2003 578
2004 671
2005 914
2006 1003
2007 1168
2008 1348
2009 1230
2010 1374
2011 1420
2012 1502
2013 1403
2014 1526
2015 1564
2016 1755
2017 1737
2018 1829
2019 2075
2020 2528
2021 2641
2022 2677
2023 2465
2024 827

Text availability

Article attribute

Article type

Publication date

Search Results

36,006 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics and pharmacodynamics of cannabinoids.
Grotenhermen F. Grotenhermen F. Clin Pharmacokinet. 2003;42(4):327-60. doi: 10.2165/00003088-200342040-00003. Clin Pharmacokinet. 2003. PMID: 12648025 Review.
However, its acid metabolite THC-COOH, the non-psychotropic cannabidiol (CBD), several cannabinoid analogues and newly discovered modulators of the endogenous cannabinoid system are also promising candidates for clinical research and therapeutic uses. Cannabinoid
However, its acid metabolite THC-COOH, the non-psychotropic cannabidiol (CBD), several cannabinoid analogues and newly discovered mod …
Medical Use of Cannabinoids.
Fraguas-Sánchez AI, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1. Drugs. 2018. PMID: 30374797 Review.
Cannabinoids have shown promise as analgesics for the treatment of both inflammatory and neuropathic pain. ...Considering the importance of the endocannabinoid system and the therapeutic potential of cannabinoids in this vast number of medical conditions, several cl
Cannabinoids have shown promise as analgesics for the treatment of both inflammatory and neuropathic pain. ...Considering the importa
Cannabinoids and Their Receptors in Skin Diseases.
Yoo EH, Lee JH. Yoo EH, et al. Int J Mol Sci. 2023 Nov 20;24(22):16523. doi: 10.3390/ijms242216523. Int J Mol Sci. 2023. PMID: 38003712 Free PMC article. Review.
The therapeutic application of cannabinoids has gained traction in recent years. Cannabinoids interact with the human endocannabinoid system in the skin. A large body of research indicates that cannabinoids could hold promise for the treatment of eczema, psor …
The therapeutic application of cannabinoids has gained traction in recent years. Cannabinoids interact with the human endocann …
Cannabinoids: Emerging sleep modulator.
Low ZXB, Lee XR, Soga T, Goh BH, Alex D, Kumari Y. Low ZXB, et al. Biomed Pharmacother. 2023 Sep;165:115102. doi: 10.1016/j.biopha.2023.115102. Epub 2023 Jul 3. Biomed Pharmacother. 2023. PMID: 37406510 Free article. Review.
Cannabinoids, a group of lipid metabolites, are regulatory molecules that bind mainly to cannabinoid receptors (CB(1) and CB(2)). ...Thus, it is crucial to understand the neurobiological basis of cannabinoids in sleep physiology. In this review article, the a
Cannabinoids, a group of lipid metabolites, are regulatory molecules that bind mainly to cannabinoid receptors (CB(1) and CB(2
Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Cristino L, Bisogno T, Di Marzo V. Cristino L, et al. Nat Rev Neurol. 2020 Jan;16(1):9-29. doi: 10.1038/s41582-019-0284-z. Epub 2019 Dec 12. Nat Rev Neurol. 2020. PMID: 31831863 Review.
Anecdotal evidence that cannabis preparations have medical benefits together with the discovery of the psychotropic plant cannabinoid delta(9)-tetrahydrocannabinol (THC) initiated efforts to develop cannabinoid-based therapeutics. ...The approvals of nabiximols, a m …
Anecdotal evidence that cannabis preparations have medical benefits together with the discovery of the psychotropic plant cannabinoid
Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.
Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Castaneto MS, et al. Drug Alcohol Depend. 2014 Nov 1;144:12-41. doi: 10.1016/j.drugalcdep.2014.08.005. Epub 2014 Aug 18. Drug Alcohol Depend. 2014. PMID: 25220897 Free PMC article. Review.
BACKGROUND: Synthetic cannabinoids (SC) are a heterogeneous group of compounds developed to probe the endogenous cannabinoid system or as potential therapeutics. ...In the early 2000s, SC became popular as "legal highs" under brand names such as Spice and K2, in par …
BACKGROUND: Synthetic cannabinoids (SC) are a heterogeneous group of compounds developed to probe the endogenous cannabinoid s …
Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
Maia J, Fonseca BM, Teixeira N, Correia-da-Silva G. Maia J, et al. Biochem Pharmacol. 2023 Sep;215:115686. doi: 10.1016/j.bcp.2023.115686. Epub 2023 Jul 16. Biochem Pharmacol. 2023. PMID: 37463627 Free article. Review.
Cannabinoids are compounds found in the cannabis sativa plant. Cannabinoids, such as delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), have potential therapeutic benefits in various medical conditions. ...Dysregulation of this process is associated with seve
Cannabinoids are compounds found in the cannabis sativa plant. Cannabinoids, such as delta-9-tetrahydrocannabinol (THC) and ca
Exosomal delivery of cannabinoids against cancer.
Kaur S, Nathani A, Singh M. Kaur S, et al. Cancer Lett. 2023 Jul 10;566:216243. doi: 10.1016/j.canlet.2023.216243. Epub 2023 May 29. Cancer Lett. 2023. PMID: 37257632 Review.
Currently, Delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids (e.g., CBG, THCV, CBC), are being explored for their anticancer and anti-proliferative properties. ...We have also enumerated the role of EVs containing cannabinoids against vari …
Currently, Delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids (e.g., CBG, THCV, CBC), are being explored fo …
Cannabinoids: from pot to lab.
Papaseit E, Pérez-Mañá C, Pérez-Acevedo AP, Hladun O, Torres-Moreno MC, Muga R, Torrens M, Farré M. Papaseit E, et al. Int J Med Sci. 2018 Aug 6;15(12):1286-1295. doi: 10.7150/ijms.27087. eCollection 2018. Int J Med Sci. 2018. PMID: 30275754 Free PMC article. Review.
In recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and the medical (pharmaceutical cannabinoids and medical cannabis) has been crossed. ...We have also analyzed serious adverse reactions a …
In recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and …
Role of Cannabinoids in Various Diseases: A Review.
Kaur S, Sharma N, Roy A. Kaur S, et al. Curr Pharm Biotechnol. 2022;23(11):1346-1358. doi: 10.2174/1389201023666211223164656. Curr Pharm Biotechnol. 2022. PMID: 34951355 Review.
OBJECTIVES: This review aims to provide an overview of the role of cannabinoids in various diseases like metabolic disorders, infectious diseases, and psychological disorders. ...Here we tried to summarize the therapeutic aspect of Cannabis sativa and its bioactive compoun …
OBJECTIVES: This review aims to provide an overview of the role of cannabinoids in various diseases like metabolic disorders, infecti …
36,006 results
You have reached the last available page of results. Please see the User Guide for more information.